OBJECTIVE: Twin and family studies suggest that genetic variants contribute to the pathogenesis of bulimia nervosa (BN) and anorexia nervosa (AN). The Price Foundation has supported an international, multisite study of families with these disorders to identify these genetic variations. The current study presents the clinical characteristics of this sample as well as a description of the study methodology. METHOD: All probands met modified criteria for BN or bulimia nervosa with a history of AN (BAN) as defined in the 4th ed. of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric Association, 1994). All affected relatives met DSM-IV criteria for BN, AN, BAN, or eating disorders not otherwise specified (EDNOS). Probands and affected relatives were assessed diagnostically using both trained-rater and self-report assessments. DNA samples were collected from probands, affected relatives, and available biologic parents. RESULTS: Assessments were obtained from 163 BN probands and 165 BAN probands. Overall, there were 365 relative pairs available for linkage analysis. Of the affected relatives of BN probands, 62 were diagnosed as BN (34.8%), 49 as BAN (27.5%), 35 as AN (19.7%), and 32 as EDNOS (18.0%). For the relatives of BAN probands, 42 were diagnosed as BN (22.5%), 67 as BAN (35.8%), 48 as AN (25.7%), and 30 as EDNOS (16.0%). DISCUSSION: This study represents the largest genetic study of eating disorders to date. Clinical data indicate that although there are a large number of individuals with BN disorders, a range of eating pathology is represented in the sample, allowing for the examination of several different phenotypes in molecular genetic analyses. Copyright 2004 by Wiley Periodicals, Inc. Int J Eat Disord 35: 556-570, 2004.
OBJECTIVE: Twin and family studies suggest that genetic variants contribute to the pathogenesis of bulimia nervosa (BN) and anorexia nervosa (AN). The Price Foundation has supported an international, multisite study of families with these disorders to identify these genetic variations. The current study presents the clinical characteristics of this sample as well as a description of the study methodology. METHOD: All probands met modified criteria for BN or bulimia nervosa with a history of AN (BAN) as defined in the 4th ed. of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; American Psychiatric Association, 1994). All affected relatives met DSM-IV criteria for BN, AN, BAN, or eating disorders not otherwise specified (EDNOS). Probands and affected relatives were assessed diagnostically using both trained-rater and self-report assessments. DNA samples were collected from probands, affected relatives, and available biologic parents. RESULTS: Assessments were obtained from 163 BN probands and 165 BAN probands. Overall, there were 365 relative pairs available for linkage analysis. Of the affected relatives of BN probands, 62 were diagnosed as BN (34.8%), 49 as BAN (27.5%), 35 as AN (19.7%), and 32 as EDNOS (18.0%). For the relatives of BAN probands, 42 were diagnosed as BN (22.5%), 67 as BAN (35.8%), 48 as AN (25.7%), and 30 as EDNOS (16.0%). DISCUSSION: This study represents the largest genetic study of eating disorders to date. Clinical data indicate that although there are a large number of individuals with BN disorders, a range of eating pathology is represented in the sample, allowing for the examination of several different phenotypes in molecular genetic analyses. Copyright 2004 by Wiley Periodicals, Inc. Int J Eat Disord 35: 556-570, 2004.
Authors: Cynthia M Bulik; Silviu-Alin Bacanu; Kelly L Klump; Manfred M Fichter; Katherine A Halmi; Pamela Keel; Allan S Kaplan; James E Mitchell; Alessandro Rotondo; Michael Strober; Janet Treasure; D Blake Woodside; Vibhor A Sonpar; Weiting Xie; Andrew W Bergen; Wade H Berrettini; Walter H Kaye; Bernie Devlin Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2005-11-05 Impact factor: 3.568
Authors: Silviu-Alin Bacanu; Cynthia M Bulik; Kelly L Klump; Manfred M Fichter; Katherine A Halmi; Pamela Keel; Allan S Kaplan; James E Mitchell; Alessandro Rotondo; Michael Strober; Janet Treasure; D Blake Woodside; Vibhor A Sonpar; Weiting Xie; Andrew W Bergen; Wade H Berrettini; Walter H Kaye; Bernie Devlin Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2005-11-05 Impact factor: 3.568
Authors: Cinnamon S Bloss; Wade Berrettini; Andrew W Bergen; Pierre Magistretti; Vikas Duvvuri; Michael Strober; Harry Brandt; Steve Crawford; Scott Crow; Manfred M Fichter; Katherine A Halmi; Craig Johnson; Allan S Kaplan; Pamela Keel; Kelly L Klump; James Mitchell; Janet Treasure; D Blake Woodside; Enrica Marzola; Nicholas J Schork; Walter H Kaye Journal: Neuropsychopharmacology Date: 2011-07-13 Impact factor: 7.853
Authors: Nancy Zucker; Ann Von Holle; Laura M Thornton; Michael Strober; Kathy Plotnicov; Kelly L Klump; Harry Brandt; Steve Crawford; Scott Crow; Manfred M Fichter; Katherine A Halmi; Craig Johnson; Allan S Kaplan; Pamela Keel; Maria LaVia; James E Mitchell; Alessandro Rotondo; D Blake Woodside; Wade H Berrettini; Walter H Kaye; Cynthia M Bulik Journal: J Clin Psychol Date: 2011-01-03
Authors: Stephanie Zerwas; Brian C Lund; Ann Von Holle; Laura M Thornton; Wade H Berrettini; Harry Brandt; Steven Crawford; Manfred M Fichter; Katherine A Halmi; Craig Johnson; Allan S Kaplan; Maria La Via; James Mitchell; Alessandro Rotondo; Michael Strober; D Blake Woodside; Walter H Kaye; Cynthia M Bulik Journal: J Psychiatr Res Date: 2013-03-25 Impact factor: 4.791
Authors: Lauren Reba-Harrelson; Ann Von Holle; Laura M Thornton; Kelly L Klump; Wade H Berrettini; Harry Brandt; Steven Crawford; Scott Crow; Manfred M Fichter; David Goldman; Katherine A Halmi; Craig Johnson; Allan S Kaplan; Pamela Keel; Maria LaVia; James Mitchell; Katherine Plotnicov; Alessandro Rotondo; Michael Strober; Janet Treasure; D Blake Woodside; Walter H Kaye; Cynthia M Bulik Journal: Eat Behav Date: 2007-05-03
Authors: M J Jacobs; S Roesch; S A Wonderlich; R Crosby; L Thornton; D E Wilfley; W H Berrettini; H Brandt; S Crawford; M M Fichter; K A Halmi; C Johnson; A S Kaplan; M Lavia; J E Mitchell; A Rotondo; M Strober; D B Woodside; W H Kaye; C M Bulik Journal: Psychol Med Date: 2008-06-26 Impact factor: 7.723